Sumihare Noji Selected Research

Type 1C Limb-Girdle Muscular Dystrophy

1/2011	Atelocollagen-mediated systemic administration of myostatin-targeting siRNA improves muscular atrophy in caveolin-3-deficient mice.
11/2006	Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sumihare Noji Research Topics

Disease

4	Muscular Atrophy (Muscle Atrophy) 01/2013 - 11/2006
3	Muscular Dystrophies (Muscular Dystrophy) 01/2013 - 02/2008
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 08/2012 - 11/2006
3	Neoplasms (Cancer) 08/2012 - 09/2006
2	Hypertrophy 01/2013 - 04/2002
2	Ganglion Cysts (Ganglion) 01/2012 - 11/2005
2	Type 1C Limb-Girdle Muscular Dystrophy 01/2011 - 11/2006
1	Wounds and Injuries (Trauma) 01/2022
1	Ototoxicity 06/2015
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2014
1	Muscular Diseases (Myopathy) 04/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Intellectual Disability (Idiocy) 08/2009
1	Autoimmune Diseases (Autoimmune Disease) 11/2008
1	Retinoblastoma (Glioblastoma, Retinal) 11/2008
1	Periodontal Diseases (Periodontal Disease) 01/2004
1	Inflammation (Inflammations) 01/2004
1	Bacterial Infections (Bacterial Infection) 01/2004
1	Necrosis 01/2004
1	Polydactyly (Polydactylism) 05/2002
1	Hyperplasia 04/2002

Drug/Important Bio-Agent (IBA)

6	MyostatinIBA 04/2014 - 04/2002
4	Small Interfering RNA (siRNA)IBA 04/2014 - 10/2010
3	Caveolin 3IBA 01/2013 - 11/2006
2	Therapeutic UsesIBA 06/2015 - 01/2013
2	Pharmaceutical PreparationsIBA 06/2015 - 08/2012
2	atelocollagenIBA 01/2013 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 11/2008
1	Liposomes (Liposome)IBA 04/2014
1	DystrophinIBA 04/2014
1	fibroblast growth factor 21IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Ki26894IBA 08/2012
1	CaveolinsIBA 08/2012
1	Phosphotransferases (Kinase)IBA 08/2012
1	Transforming Growth Factor-beta Type I ReceptorIBA 08/2012
1	LuciferasesIBA 10/2010
1	Dopamine Receptors (Dopamine Receptor)IBA 08/2009
1	Estrogens (Estrogen)FDA Link 11/2008
1	LipidsIBA 09/2006
1	lysophosphatidic acidIBA 09/2006
1	Biological ProductsIBA 09/2006
1	melanopsinIBA 11/2005
1	Interleukin-8 (Interleukin 8)IBA 01/2004
1	InterleukinsIBA 01/2004
1	CytokinesIBA 01/2004
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004
1	Tuberculin (PPD)IBA 05/2002

Therapy/Procedure

2	Therapeutics 08/2012 - 11/2006
1	Surgical Amputation (Amputations) 01/2022
1	Oral Administration 08/2012